Brii Bio's ENSURE Study Unveils Promising HBsAg Clearance Data At EASL Congress 2025#USA#Durham#Brii_Bio#BRII-179#ENSURE_Study
Brii Bio's ENSURE Study Unveils Promising HBsAg Clearance Data At EASL Congress 2025
Exciting new data from Brii Bio's ongoing ENSURE study highlights BRII-179's effectiveness in enhancing HBsAg seroclearance rates in HBV patients, offering hope for better treatment outcomes.
third-news.com
May 8, 2025 at 12:13 AM
Brii Bio's ENSURE Study Unveils Promising HBsAg Clearance Data At EASL Congress 2025#USA#Durham#Brii_Bio#BRII-179#ENSURE_Study
Brii Biosciences Unveils Promising Data on BRII-179 in Phase 2 ENSURE Study at APASL 2025#BRII-179#Brii_Biosciences#ENSURE_Study
Brii Biosciences Unveils Promising Data on BRII-179 in Phase 2 ENSURE Study at APASL 2025
Brii Biosciences Limited presented exciting findings at APASL 2025, indicating BRII-179's potential to enhance HBsAg loss in chronic HBV patients, paving the way for future treatments.
third-news.com
March 30, 2025 at 11:22 AM
Brii Biosciences Unveils Promising Data on BRII-179 in Phase 2 ENSURE Study at APASL 2025#BRII-179#Brii_Biosciences#ENSURE_Study